Cosara produces fast, accurate, and affordable PCR test kits in its Good Manufacturing Practices (GMP) facility enabling more extensive testing coverage for diagnosis and monitoring of diseases such as hepatitis, tuberculosis, covid-19, dengue, and chikungunya.

With a focus on innovation, Cosara has the expertise and is working to adapt the technology of molecular testing to new diseases, to meet the need of patients worldwide for this crucial component of today’s healthcare.